Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality is a research paper published in UNC Libraries (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AI099026-03
Optimizing the impact of Xpert MTB/RIF on treatment outcomes of drug resistant TB
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals